First Physicians Capital Group Inc
OTC:FPCG
Relative Value
There is not enough data to reliably calculate the relative value of FPCG.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
FPCG Competitors Multiples
First Physicians Capital Group Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
F
|
First Physicians Capital Group Inc
OTC:FPCG
|
10.1m USD | 0.4 | 1.1 | 1.4 | 1.4 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
96.8B USD | 0.2 | 206.4 | 13.7 | 13.7 | |
| US |
|
Cigna Corp
NYSE:CI
|
78.3B USD | 0.3 | 12.7 | 0 | 0 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
65.4B EUR | 0.3 | 12.5 | 8 | 10.1 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
28B EUR | 1.2 | 24.4 | 10.7 | 16.2 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.7B EUR | 1.2 | 33 | 10.4 | 22.2 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.8B USD | 1.7 | 26.7 | 14.4 | 20.1 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.2B USD | 2 | 22.3 | 12.2 | 16.4 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.5B EUR | 0.6 | 15.8 | 6.3 | 13.5 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
13.2B USD | 14.7 | -33.2 | -35 | -31.8 | |
| US |
|
DaVita Inc
NYSE:DVA
|
9.8B USD | 0.7 | 12.7 | 7.3 | 9.9 |